Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
Authors:
- María del Mar TavíoMTMaría del Mar Tavío
- Jordi VilaJordi Vila
- Joaquím RuizJRJoaquím Ruiz
- José RuizJRJosé Ruiz
- Antonio Manuel Martín-SánchezAMAntonio Manuel Martín-Sánchez
- María Teresa Jiménez de AntaMAMaría Teresa Jiménez de Anta
Open Access
- 1 December 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (6) , 735-742
Abstract
Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n= 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤12 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.Keywords
This publication has 21 references indexed in Scilit:
- AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutantsJournal of Bacteriology, 1996
- Proton-dependent multidrug efflux systems.Microbiological Reviews, 1996
- Mechanisms of Resistance to FluoroquinolonesDrugs, 1995
- Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICsAntimicrobial Agents and Chemotherapy, 1994
- The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coliJournal of Antimicrobial Chemotherapy, 1993
- Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acidAntimicrobial Agents and Chemotherapy, 1991
- 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reactionAntimicrobial Agents and Chemotherapy, 1991
- Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteinsAntimicrobial Agents and Chemotherapy, 1991
- Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reductionAntimicrobial Agents and Chemotherapy, 1989
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coliAntimicrobial Agents and Chemotherapy, 1986